As thought leaders, we are asked to participate on a variety of advisory boards to represent the interest and perspective of lung cancer patients.

We are honored to serve on these committees:

  • National Cancer Institute’s Thoracic Malignancy Steering Committee (2016 – 2019)
  • National Cancer Institute’s Patient Advocate Steering Committee (2016 – 2019)
  • National Cancer Institute’s Council of Research Advocates (2012 – 2015)
  • ACCC Advisory Committee - Optimal Care Coordination Model for Medicaid Patients with Lung Cancer (2016 - present)
  • ACCC Advisory Committee for Molecular Testing NSCLC Initiative (2016 - present )
  • American Association for Cancer Researcher (AACR), Cancer Today Editorial Advisory Board (2016 – 2018)
  • SITC’s Cancer Immunotherapy Guidelines – Lung Cancer (CIG-LC) Task Force (2016 -  present)
  • Friends of Cancer Research Immuno-oncology Policy Working Group member (2015 – present)
  • FasterCures’ Benefit-Risk Advisory Council (2015 – present)
  • Team member of Stand Up to Cancer Lung Cancer Dream Team (2015 – 2018)
  • Cancer Innovation Council Pathways Working Group member (2015 – present)
  • The Recalcitrant Cancer Act Small Cell Lung Cancer Advisory
  • LungMAP’s Patient Advisory Committee

We are a member of these organizations:

State Cancer Coalitions:


We believe it is important to work in partnership with other organizations to ensure the best possible outcomes for patients.

We are proud to collaborate with these organizations: